Encapsulated cell technology: from research to market

Trends Biotechnol. 2002 Sep;20(9):382-7. doi: 10.1016/s0167-7799(02)02037-1.

Abstract

Encapsulated cell technology has the potential to treat a wide range of diseases by the controlled and continuous delivery of biological products to the host. Many biotechnology companies have focused their interest in this technology taking into account the promising pre-clinical and clinical results and the potential clinical market. However, on the long way from clinic to market several issues will have to be addressed, including suitable scientific development, ethical obstacles, government regulations and market forces.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biotechnology / economics*
  • Biotechnology / legislation & jurisprudence
  • Capsules*
  • Cell Transplantation / economics*
  • Cell Transplantation / legislation & jurisprudence
  • Cell Transplantation / methods*
  • Cell Transplantation / trends
  • Coated Materials, Biocompatible
  • Commerce
  • Delayed-Action Preparations / economics
  • Denmark
  • Drug Carriers / economics
  • Drug Delivery Systems / economics*
  • Drug Delivery Systems / methods*
  • Drug Delivery Systems / trends
  • Drug Evaluation
  • Drug Industry / economics
  • France
  • Humans
  • United States

Substances

  • Capsules
  • Coated Materials, Biocompatible
  • Delayed-Action Preparations
  • Drug Carriers